Investment
Features
FeesSafety
Academy
More
Pluang+

QuickLogic grants 51,502 restricted stock units to new CFO James Sullivan as part of his hiring package.

Company Fundamentals
06 Oct 2026
PRNewsWire
View Source
Neutral
QuickLogic grants 51,502 restricted stock units to new CFO James Sullivan as part of his hiring package.

QuickLogic Corporation awarded 51,502 restricted stock units (RSUs) to its new Senior Vice President of Finance and CFO, James Sullivan, as an incentive for joining the company. These RSUs were granted outside the company's 2019 Equity Incentive Plan and will vest over three years, starting with one-third vesting after one year and the remainder vesting in six-month intervals, contingent on Sullivan's continued employment. This move aligns with Nasdaq rules and aims to retain key executive talent. QuickLogic specializes in embedded FPGA and programmable logic solutions for various industries including aerospace and defense.

QuickLogic's inducement grant news is presented with Technology-sector market data from Pluang as of Oct 07, 2026 03:03 WIB. Among 150 priced Technology-sector US stocks, 93 rose and 56 fell today. Notable movers include AEHR at USD 92.81 with a 1-day change of -11.10%, STX at USD 806.00 with a 1-day change of -9.14%, and FRSH at USD 13.79 with a 1-day change of +7.90%.

More News

Constellation Brands beats earnings and revenue estimates with strong beer and spirits sales.

Constellation Brands beats earnings and revenue estimates with strong beer and spirits sales.

Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...

Company Fundamentals
Bullish
2 hours ago
Tilray Brands to report Q1 2027 results with expected revenue growth and ongoing losses

Tilray Brands to report Q1 2027 results with expected revenue growth and ongoing losses

Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...

Company Fundamentals
Neutral
2 hours ago
Five stocks jump 21%-53% on news of acquisitions, blockchain, AI, and federal financing.

Five stocks jump 21%-53% on news of acquisitions, blockchain, AI, and federal financing.

On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...

Market News
Bullish
2 hours ago
Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.

Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.

On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...

Market News
Bearish
2 hours ago
Evercore raises Marvell's price target to $433 on strong AI and data center growth forecasts.

Evercore raises Marvell's price target to $433 on strong AI and data center growth forecasts.

Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App